Bacterial Vesicles Deliver Antimicrobial Peptide LL-37 Derivative for Enhanced Pathogen Killing | Research

The takeaway

Bacterial extracellular vesicles from S. parauberis efficiently delivered the human cathelicidin-derived AMP LL-37 derivative, enabling enhanced antimicrobial activity through biological nanocarrier delivery.

Nature's delivery system
Bacteria's own vesicles serve as natural nanocarriers for antimicrobial peptide delivery, enhancing activity vs free peptide

What the researchers found

BEVs from S. parauberis efficiently delivered human cathelicidin-derived AMP, enhancing antimicrobial activity compared to free peptide through biological nanocarrier delivery.

Why it matters

AMP delivery is a major challenge. Using bacteria's own vesicles as natural nanocarriers could improve both stability and cellular uptake of therapeutic peptides.

How the study worked

BEV isolation from S. parauberis, LL-37 derivative loading, characterization, and antimicrobial activity comparison vs free peptide.

What this study cannot tell us

In vitro. Single AMP tested. BEV production scalability and safety need assessment.

How to read the evidence

In vitro proof-of-concept. Novel biological delivery approach.

When this study was published

Published in 2025.

The bigger picture

Biological nanocarriers from bacteria represent a new delivery paradigm for antimicrobial peptides — natural vehicles evolved for molecular transport.

Questions still open

Could BEVs deliver AMPs systemically without immunogenicity?
What other AMPs benefit from BEV delivery?
How does BEV-AMP stability compare to synthetic nanoparticle delivery?

Common questions

What are bacterial extracellular vesicles?

Tiny membrane bubbles that bacteria naturally produce. Researchers can load them with therapeutic peptides, using bacteria's own delivery system to transport medicine.

Is this better than regular nanoparticles?

BEVs are naturally biocompatible and evolved for molecular transport. This study showed they enhanced AMP antimicrobial activity compared to free peptide delivery.

Read the original research

Extracellular vesicles from Streptococcus parauberis facilitate the efficient delivery of LL37 with enhanced antibacterial activity.

Fish & shellfish immunology, 168, 110989

View on PubMed ↗Publisher’s paper ↗

Citation

Jayathilaka, E H T Thulshan; Dias, Mawallage Kankanamge Hasitha Madhawa; Nikapitiya, Chamilani; De Zoysa, Mahanama. (2026). Extracellular vesicles from Streptococcus parauberis facilitate the efficient delivery of LL37 with enhanced antibacterial activity.. Fish & shellfish immunology, 168, 110989. https://doi.org/10.1016/j.fsi.2025.110989